COVID-19 pandemic
The government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.
Sources: Kyodo News
Changes
- The Japanese government approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, becoming the first vaccine to be used for children in the country.
- The government approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 12 to 15, becoming the first vaccine to be used for children in Japan.
- The government approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 12 and 15, becoming the first vaccine to be approved used for children in Japan.